T cell receptor restriction of diabetogenic autoimmune NOD T cells.
暂无分享,去创建一个
G. Eisenbarth | D. Wegmann | S. Babu | P. Gottlieb | N. Schloot | G S Eisenbarth | E. Kawasaki | E Simone | D Daniel | N Schloot | P Gottlieb | S Babu | E Kawasaki | D Wegmann | D. Daniel | N. Schloot | S. Babu | E. Simone
[1] H. Wekerle,et al. T cell receptor β chain usage in myelin basic protein‐specific rat T lymphocytes , 1989 .
[2] D. Wegmann,et al. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[3] H. Kikutani,et al. T cell receptor V gene usage of islet beta cell-reactive T cells is not restricted in non-obese diabetic mice , 1991, The Journal of experimental medicine.
[4] A. Rostami,et al. Shared T‐cell receptor gene usage in experimental allergic neuritis and encephalomyelitis , 1992, Annals of neurology.
[5] H. Mcdevitt,et al. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention , 1988, Cell.
[6] L. Hood,et al. Characterization of the T cell receptor repertoire causing collagen arthritis in mice , 1993, The Journal of experimental medicine.
[7] C. Fathman,et al. Genetic dissection of T cell receptor V beta gene requirements for spontaneous murine diabetes , 1991, The Journal of experimental medicine.
[8] L. Hood,et al. Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy , 1988, Cell.
[9] M. Dorf,et al. The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex. , 1986, Science.
[10] V. Brusic,et al. Similar Peptides from Two β Cell Autoantigens, Proinsulin and Glutamic Acid Decarboxylase, Stimulate T Cells of Individuals at Risk for Insulin-Dependent Diabetes , 1995, Molecular medicine.
[11] M. A. Bowman,et al. Prevention of diabetes in the NOD mouse: implications for therapeutic intervention in human disease. , 1994, Immunology today.
[12] M. Mcduffie. Diabetes in NOD Mice Does not Require T Lymphocytes Expressing Vβ8 or Vβ5 , 1991, Diabetes.
[13] R. Gill,et al. Analysis of the spontaneous T cell response to insulin in NOD mice. , 1994, Journal of autoimmunity.
[14] D. Wegmann,et al. Epitope specificity, cytokine production profile and diabetogenic activity of insulin‐specific T cell clones isolated from NOD mice , 1995, European journal of immunology.
[15] C. Benoist,et al. Islet-specific T-cell clones from nonobese diabetic mice express heterogeneous T-cell receptors. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[16] S. Tompkins,et al. An insulin peptide that binds an alternative site in class II major histocompatibility complex , 1996, The Journal of experimental medicine.
[17] J. Seidman,et al. Progression to diabetes in nonobese diabetic (NOD) mice with transgenic T cell receptors. , 1993, Science.
[18] S. Fling,et al. Conserved T cell receptor V gene usage by uveitogenic T cells. , 1991, Clinical immunology and immunopathology.
[19] J. Bach. Insulin-dependent diabetes mellitus as a beta-cell targeted disease of immunoregulation. , 1995, Journal of autoimmunity.
[20] T. Utsugi,et al. Beta-cell-cytotoxic CD8+ T cells from nonobese diabetic mice use highly homologous T cell receptor alpha-chain CDR3 sequences. , 1995, Journal of immunology.
[21] J. Krischer,et al. Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription. , 1995, The Journal of clinical investigation.
[22] D. Wegmann,et al. Insulin‐specific T cells are a predominant component of islet infiltrates in pre‐diabetic NOD mice , 1994, European journal of immunology.